Trek Financial LLC Purchases New Holdings in Invesco Pharmaceuticals ETF $PJP

Trek Financial LLC purchased a new position in shares of Invesco Pharmaceuticals ETF (NYSEARCA:PJP) during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor purchased 46,386 shares of the company’s stock, valued at approximately $5,720,000.

A number of other institutional investors and hedge funds have also recently modified their holdings of PJP. Envestnet Asset Management Inc. lifted its position in shares of Invesco Pharmaceuticals ETF by 35.9% during the 2nd quarter. Envestnet Asset Management Inc. now owns 36,897 shares of the company’s stock valued at $4,370,000 after acquiring an additional 9,741 shares during the period. Royal Bank of Canada boosted its stake in Invesco Pharmaceuticals ETF by 479.8% during the first quarter. Royal Bank of Canada now owns 62,377 shares of the company’s stock worth $6,472,000 after acquiring an additional 51,619 shares in the last quarter. Bank of America Corp DE boosted its stake in Invesco Pharmaceuticals ETF by 234.0% during the first quarter. Bank of America Corp DE now owns 74,458 shares of the company’s stock worth $7,726,000 after acquiring an additional 52,165 shares in the last quarter. Cetera Investment Advisers grew its holdings in Invesco Pharmaceuticals ETF by 250.7% in the first quarter. Cetera Investment Advisers now owns 20,462 shares of the company’s stock worth $2,123,000 after purchasing an additional 14,628 shares during the period. Finally, Outlook Wealth Advisors LLC acquired a new stake in Invesco Pharmaceuticals ETF in the third quarter worth $1,392,000.

Invesco Pharmaceuticals ETF Price Performance

PJP stock opened at $130.54 on Monday. The company’s 50-day moving average is $125.80 and its 200-day moving average is $114.46. The stock has a market capitalization of $579.60 million, a PE ratio of 15.59 and a beta of 0.44. Invesco Pharmaceuticals ETF has a 1 year low of $95.43 and a 1 year high of $131.88.

Invesco Pharmaceuticals ETF Company Profile

PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors. The Index consists of stocks of 30 United States pharmaceutical companies. These are companies that are principally engaged in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types.